Previous close | 0.5998 |
Open | 0.5896 |
Bid | 0.6000 x 800 |
Ask | 0.6700 x 900 |
Day's range | 0.5896 - 0.6690 |
52-week range | 0.2300 - 1.4800 |
Volume | |
Avg. volume | 120,455 |
Market cap | 51.983M |
Beta (5Y monthly) | 1.54 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
SEATTLE, May 09, 2024--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it has been selected for an oral abstract presentation at the American Association of Clinical Endocrinology (AACE) Annual Meeting in New Orleans, Louisiana on May 9, 2024 from 11:15 a.m. – 11:30 a.m. CDT.
SEATTLE, May 08, 2024--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it will host a webcast to review business updates and results for its second quarter of the fiscal year 2024 ended on March 31, 2024, on May 15, 2024, beginning at 1:30 pm PT.
SEATTLE, April 05, 2024--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it has been selected for an abstract poster presentation at the American Physiological Society (APS) Summit in Long Beach, California on April 4-7, 2024.